These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9225069)

  • 1. Morphological changes and apoptosis in bone marrow from patients with myelodysplastic syndromes treated with granulocyte-CSF and erythropoietin.
    Hellström-Lindberg E; Kanter-Lewensohn L; Ost A
    Leuk Res; 1997 May; 21(5):415-25. PubMed ID: 9225069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human granulocyte-macrophage colony-stimulating factor plus recombinant human erythropoietin may improve anemia in selected patients with myelodysplastic syndromes.
    Hansen PB; Johnsen HE; Hippe E; Hellström-Lindberg E; Ralfkiaer E
    Am J Hematol; 1993 Dec; 44(4):229-36. PubMed ID: 8237992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth analysis of marrow CD34-positive hematopoietic progenitor cells in patients with myelodysplastic syndromes.
    Asano H; Hotta T; Ichihara M; Murate T; Kobayashi M; Saito H
    Leukemia; 1994 May; 8(5):833-8. PubMed ID: 7514249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematopoietic growth factors for the treatment of myelodysplastic syndromes.
    Hast R; Bernell P
    Acta Haematol Pol; 1991; 22(2):203-7. PubMed ID: 1726768
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of growth factors in the regulation of apoptosis in low-risk myelodysplastic syndromes.
    Tehranchi R
    Med Oncol; 2006; 23(1):37-49. PubMed ID: 16645228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myelodysplastic syndromes in the elderly: the role of growth factors in management.
    Saba HI
    Leuk Res; 1996 Mar; 20(3):203-19. PubMed ID: 8637215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered oncoprotein expression and apoptosis in myelodysplastic syndrome marrow cells.
    Rajapaksa R; Ginzton N; Rott LS; Greenberg PL
    Blood; 1996 Dec; 88(11):4275-87. PubMed ID: 8943864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved multilineage response of hematopoiesis in patients with myelodysplastic syndromes to a combination therapy with all-trans-retinoic acid, granulocyte colony-stimulating factor, erythropoietin and alpha-tocopherol.
    Ganser A; Maurer A; Contzen C; Seipelt G; Ottmann OG; Schadeck-Gressel C; Kolbe K; Haas R; Zander C; Reutzel R; Hoelzer D
    Ann Hematol; 1996 Apr; 72(4):237-44. PubMed ID: 8624378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocyte colony-stimulating factor inhibits spontaneous cytochrome c release and mitochondria-dependent apoptosis of myelodysplastic syndrome hematopoietic progenitors.
    Tehranchi R; Fadeel B; Forsblom AM; Christensson B; Samuelsson J; Zhivotovsky B; Hellstrom-Lindberg E
    Blood; 2003 Feb; 101(3):1080-6. PubMed ID: 12393561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal growth of haemopoietic progenitor cells from myelodysplastic marrow in response to recombinant haemopoietins.
    Baines P; Bowen D; Jacobs A
    Leuk Res; 1990; 14(3):247-53. PubMed ID: 1690828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The combined effects of Il-3, GM-CSF and G-CSF on the in vitro growth of myelodysplastic myeloid progenitor cells.
    Schipperus MR; Sonneveld P; Lindemans J; Vink N; Vlastuin M; Hagemeijer A; Abels J
    Leuk Res; 1990; 14(11-12):1019-25. PubMed ID: 1704083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptosis as a parameter of cytokine treatment in myelodysplasia.
    Yoshida Y
    Leuk Res; 1997 May; 21(5):427-8. PubMed ID: 9225070
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of anaemia in myelodysplastic syndromes with prolonged administration of recombinant human granulocyte colony-stimulating factor and erythropoietin.
    Mantovani L; Lentini G; Hentschel B; Wickramanayake PD; Loeffler M; Diehl V; Tesch H
    Br J Haematol; 2000 May; 109(2):367-75. PubMed ID: 10848827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythroid response to treatment with G-CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: proposal for a predictive model.
    Hellström-Lindberg E; Negrin R; Stein R; Krantz S; Lindberg G; Vardiman J; Ost A; Greenberg P
    Br J Haematol; 1997 Nov; 99(2):344-51. PubMed ID: 9375752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct signal transduction abnormalities and erythropoietin response in bone marrow hematopoietic cell subpopulations of myelodysplastic syndrome patients.
    Spinelli E; Caporale R; Buchi F; Masala E; Gozzini A; Sanna A; Sassolini F; Valencia A; Bosi A; Santini V
    Clin Cancer Res; 2012 Jun; 18(11):3079-89. PubMed ID: 22496271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintenance treatment of the anemia of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor and erythropoietin: evidence for in vivo synergy.
    Negrin RS; Stein R; Doherty K; Cornwell J; Vardiman J; Krantz S; Greenberg PL
    Blood; 1996 May; 87(10):4076-81. PubMed ID: 8639764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proliferation and differentiation of myelodysplastic CD34+ cells in serum-free medium: response to individual colony-stimulating factors.
    Sawada K; Sato N; Tarumi T; Sakai N; Koizumi K; Sakurama S; Ieko M; Yasukouchi T; Koyanagawa Y; Yamaguchi M
    Br J Haematol; 1993 Mar; 83(3):349-58. PubMed ID: 7683482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro growth of myeloid and erythroid progenitor cells from myelodysplastic patients in response to recombinant human granulocyte-macrophage colony-stimulating factor.
    Mayani H; Baines P; Bowen DT; Jacobs A
    Leukemia; 1989 Jan; 3(1):29-32. PubMed ID: 2642575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone.
    Musto P; Sanpaolo G; D'Arena G; Scalzulli PR; Matera R; Falcone A; Bodenizza C; Perla G; Carotenuto M
    Haematologica; 2001 Jan; 86(1):44-51. PubMed ID: 11146570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin + granulocyte colony-stimulating factor: significant effects on quality of life.
    Hellström-Lindberg E; Gulbrandsen N; Lindberg G; Ahlgren T; Dahl IM; Dybedal I; Grimfors G; Hesse-Sundin E; Hjorth M; Kanter-Lewensohn L; Linder O; Luthman M; Löfvenberg E; Oberg G; Porwit-MacDonald A; Rådlund A; Samuelsson J; Tangen JM; Winquist I; Wisloff F;
    Br J Haematol; 2003 Mar; 120(6):1037-46. PubMed ID: 12648074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.